← Leaderboards
Polly Yee Chang
University Of Calif-Lawrenc Berkeley Lab
$16,021,910
Attributed
$19,402,464
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.1M · FY2009–25$20M$15M$10M$5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,402,464 · 2
By mechanism
N01$15,176,771 · 1
RC2$4,225,693 · 1
Top collaborators
- Rebecca J Abergel2 shared
- Eleanor A Blakely2 shared
- Kenneth N Raymond2 shared
- David K Shuh2 shared
Most similar at University Of Calif-Lawrenc Berkeley Lab
Same institution · by research overlap
- Rebecca J Abergel$2,229,966
- Daojing Wang$14,771,713
- Martha R Stampfer$2,755,184
- Eleanor A Blakely$845,139
- David K Shuh$845,139
Others in their field
Top investigators on “Exposure To”
- Chanza Baytop · Westat, Inc.$271,217,917
- Dennis R. Burton · Scripps Research Institute$265,781,207
- Myron S Cohen · Family Health International$253,611,624
- Wafaa M. El-Sadr · Columbia University Health Sciences$253,611,624
- George R Seage · Abt Associates, Inc.$221,990,872
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$151,998,810
Research focus
Exposure ToMedical CountermeasureRadiation ExposureContractsSafety StudySamplingBiodosimetryServicesRadiation InjuriesNuclearInjuryRadioisotopesAnimal ModelToxic EffectResearch And DevelopmentRecurrenceRadiationNational Institute Of Allergy And Infectious DiseaseProduct DevelopmentRadiation ToxicityAnimal EfficacyEfficacy StudyBiological SystemsBiological Models
Grant awards (8)
DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDY$3,395,535
N01 · FY2025 · AI · contact PI
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT$645,436
N01 · FY2025 · AI · contact PI
Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support$3,435,398
N01 · FY2024 · AI · contact PI
DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDY$2,898,062
N01 · FY2024 · AI · contact PI
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT$2,668,607
N01 · FY2024 · AI · contact PI
NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS$2,133,733
N01 · FY2024 · AI · contact PI
Biomimetic Actinide Decorporation: Characterization and Preclinical Development$2,140,116
RC2 · FY2010 · AI
Biomimetic Actinide Decorporation: Characterization and Preclinical Development$2,085,577
RC2 · FY2009 · AI